569 related articles for article (PubMed ID: 30883042)
21. Reassessing the pathogenicity of c.2858G>T(p.(G953V)) in COL4A5 Gene: report of 19 Chinese families.
Zhang Y; Ding J; Wang S; Zhang H; Zhong X; Liu X; Xu K; Wang F
Eur J Hum Genet; 2020 Feb; 28(2):244-252. PubMed ID: 31576025
[TBL] [Abstract][Full Text] [Related]
22. Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.
Slajpah M; Gorinsek B; Berginc G; Vizjak A; Ferluga D; Hvala A; Meglic A; Jaksa I; Furlan P; Gregoric A; Kaplan-Pavlovcic S; Ravnik-Glavac M; Glavac D
Kidney Int; 2007 Jun; 71(12):1287-95. PubMed ID: 17396119
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
Savige J; Harraka P
Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
[TBL] [Abstract][Full Text] [Related]
24. Heterozygous Urinary Abnormality-Causing Variants of
Horinouchi T; Yamamura T; Nagano C; Sakakibara N; Ishiko S; Aoto Y; Rossanti R; Nakanishi K; Shima Y; Morisada N; Iijima K; Nozu K
Kidney360; 2020 Sep; 1(9):936-942. PubMed ID: 35369551
[TBL] [Abstract][Full Text] [Related]
25. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
[TBL] [Abstract][Full Text] [Related]
26. Expert consensus guidelines for the genetic diagnosis of Alport syndrome.
Savige J; Ariani F; Mari F; Bruttini M; Renieri A; Gross O; Deltas C; Flinter F; Ding J; Gale DP; Nagel M; Yau M; Shagam L; Torra R; Ars E; Hoefele J; Garosi G; Storey H
Pediatr Nephrol; 2019 Jul; 34(7):1175-1189. PubMed ID: 29987460
[TBL] [Abstract][Full Text] [Related]
27. Heterozygous Pathogenic
Savige J
Kidney Int Rep; 2022 Sep; 7(9):1933-1938. PubMed ID: 36090501
[TBL] [Abstract][Full Text] [Related]
28. The COL4A3 and COL4A4 Digenic Mutations in cis Result in Benign Familial Hematuria in a Large Chinese Family.
Li A; Cui YX; Lv X; Liu JH; Gao EZ; Wei XX; Xia XY; Gao CL; Liu FX; Xia ZK; Asan ; Liu ZH; Li XJ
Cytogenet Genome Res; 2018; 154(3):132-136. PubMed ID: 29742505
[TBL] [Abstract][Full Text] [Related]
29. [
Huang W; Liu CH; Li JT; Liu YJ; Li YL; Tian M; Cao GH; Zhang SF
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):732-738. PubMed ID: 37529956
[TBL] [Abstract][Full Text] [Related]
30. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
[TBL] [Abstract][Full Text] [Related]
31. Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney disease.
Lin F; Bian F; Zou J; Wu X; Shan J; Lu W; Yao Y; Jiang G; Gale DP
BMC Nephrol; 2014 Nov; 15():175. PubMed ID: 25381091
[TBL] [Abstract][Full Text] [Related]
32. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
33. Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.
Rana K; Tonna S; Wang YY; Sin L; Lin T; Shaw E; Mookerjee I; Savige J
Pediatr Nephrol; 2007 May; 22(5):652-7. PubMed ID: 17216251
[TBL] [Abstract][Full Text] [Related]
34. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.
Pierides A; Voskarides K; Athanasiou Y; Ioannou K; Damianou L; Arsali M; Zavros M; Pierides M; Vargemezis V; Patsias C; Zouvani I; Elia A; Kyriacou K; Deltas C
Nephrol Dial Transplant; 2009 Sep; 24(9):2721-9. PubMed ID: 19357112
[TBL] [Abstract][Full Text] [Related]
35. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
36. Improving mutation screening in familial hematuric nephropathies through next generation sequencing.
Morinière V; Dahan K; Hilbert P; Lison M; Lebbah S; Topa A; Bole-Feysot C; Pruvost S; Nitschke P; Plaisier E; Knebelmann B; Macher MA; Noel LH; Gubler MC; Antignac C; Heidet L
J Am Soc Nephrol; 2014 Dec; 25(12):2740-51. PubMed ID: 24854265
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.
Guo L; Li D; Dong S; Wan D; Yang B; Huang Y
J Genet; 2017 Jun; 96(2):389-392. PubMed ID: 28674241
[TBL] [Abstract][Full Text] [Related]
38. Thrombosis risk of Alport syndrome patients: evaluation of cardiological, clinical, biochemical, genetic and possible causes of inherited thrombophilia and identification of a novel COL4A3 variant.
Eroz R; Damar İH; Kılıçaslan O
Blood Coagul Fibrinolysis; 2020 Jun; 31(4):264-269. PubMed ID: 32332277
[TBL] [Abstract][Full Text] [Related]
39. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
[TBL] [Abstract][Full Text] [Related]
40. Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.
Rana K; Wang YY; Powell H; Jones C; McCredie D; Buzza M; Udawela M; Savige J
Pediatr Nephrol; 2005 Dec; 20(12):1729-37. PubMed ID: 16235097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
